Accendra Health Financials - Benzinga

Accendra Health Inc

ACHNYSE

Trade with Public

Trade with Public

$0.6045

-0.0455-7%

最終更新: Sep 29, 12:10 PM

概要ニュース業績予想目標株価財務センチメント比較オプション株式レポート

Accendra Health Financials

Accendra Health (ACH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Accendra Health Q2 Adj. EPS $(0.19) Misses $(0.09) Estimate, Sales $613.200M Miss $627.306M Estimate

Benzinga Newsdesk

PRO
Accendra Health Lowers FY2026 Sales Guidance from $2.550B-$2.650B to $2.450B-$2.550B vs $2.574B Est

Accendra Health (NYSE:ACH) lowers FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.450 billion-$2.550 billion vs $2.574 billion estimate.

Benzinga Newsdesk

PRO
Accendra Health Affirms FY2026 Sales Guidance of $2.550B-$2.650B vs $2.590B Est

Accendra Health (NYSE:ACH) affirms FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.550 billion-$2.650 billion vs $2.590 billion estimate.

Benzinga Newsdesk

Earnings Scheduled For May 11, 2026

Benzinga Insights

PRO
Accendra Health Q1 Adj. EPS $(0.04) Beats $(0.10) Estimate, Sales $627.800M Miss $644.636M Estimate

Benzinga Newsdesk

PRO
Accendra Health Sees FY2026 Sales $2.550B-$2.650B vs $2.604B Est

Accendra Health (NYSE:ACH) sees FY2026 sales of $2.550 billion-$2.650 billion vs $2.604 billion analyst estimate.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved